Nicodrops Announces the Lawsuits with GlaxoSmithKline has been Dismissed
It’s about time! The peaceful resolution of this lawsuit is obviously very welcome news. The Green Baron Report believes that now that this impediment is behind them, the Company will likely be able to communicate better with its investors. In other words, we expect a bottleneck of important developments to be finally explained to the public. In order to bring everyone up to speed, we are hoping to interview Mr. Joel Appel as soon as possible, and will try to cover a lot of ground in this webcast.
LA MESA, Calif., May 25, 2005 (PRIMEZONE via COMTEX) -- Nicodrops International Inc., a subsidiary of Nicodrops, Inc. (Other OTC: NCDP), developer of the drug-free, herbal dietary supplement smoking alternative lozenge(a), today announced an unfair competition lawsuit filed against it in February 2005 by GlaxoSmithKline Consumer Healthcare (GSK) in Federal district court in the Western District of Pennsylvania has been settled to the mutual satisfaction of the parties and has been dismissed.
"Now that the suit is behind us, we can focus all our attention on expanding the Nicodrops franchise. We are absolutely committed to building shareholder value as we move forward," said Christopher Calpito, president and CEO of Nicodrops, Inc.
About Nicodrops
Nicodrops Inc., La Mesa, CA, developed a drug-free, non-nicotine product which helps reduce the stress associated with not smoking, using all natural herbs(a). For more information go to nicodrops.com or call 1-866-844-5383.
(a) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.
Contact:
The Cervelle Group
David Donlin (407) 475-9966 or dave@thecervellegroup.com
. |
